Innovator International Developed Power Buffer ETF November
INOV
Market cap $12.4M

28.81 USD

-0.14

0.48%

Updated Nov 19, 9:30 AM EST

1 day

-0.48%

5 days

-0.07%

1 month

-2.60%

3 months

-1.06%

6 months

1.09%

Year to date

7.18%

1 year

10.09%

5 years

61.40%

10 years

6.70%

0

Funds holding %

of 6,735 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

62% more capital invested

Capital invested by funds: $1.79M [Q2] → $2.91M (+$1.11M) [Q3]

17.35% more ownership

Funds ownership: 48.56% [Q2] → 65.91% (+17.35%) [Q3]

0% more funds holding

Funds holding: 7 [Q2] → 7 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for INOV.

See Analyst Rankings

Financial journalist opinion

Inovalon Recognizes Innovators Driving Healthcare Excellence with the 2024 Impact Awards

Winners Recognized at the Annual Empower Conference for their Outstanding Achievements and Commitments to Advancing Healthcare Economics and Outcomes Across Three Categories Winners Recognized at the Annual Empower Conference for their Outstanding Achievements and Commitments to Advancing Healthcare Economics and Outcomes Across Three Categories

Inovalon Recognizes Innovators Driving Healthcare Excellence with the 2024 Impact Awards

Inovalon's Payer Cloud Ranked #1 in 2024 By Black Book Research

Health Insurance Organizations Nationwide Rank Inovalon's Payer Cloud as Top Payer Technology and Data Platform for Fourth Consecutive Year Health Insurance Organizations Nationwide Rank Inovalon's Payer Cloud as Top Payer Technology and Data Platform for Fourth Consecutive Year

Inovalon's Payer Cloud Ranked #1 in 2024 By Black Book Research

Inovalon's Converged Quality Achieves 24th Consecutive NCQA HEDIS® Certification

The Company's Solutions are Trusted by the Health Plans Representing 80% of all U.S. Covered Lives to Deliver HEDIS Results on Time, Improving Clinical Quality and Member Outcomes The Company's Solutions are Trusted by the Health Plans Representing 80% of all U.S. Covered Lives to Deliver HEDIS Results on Time, Improving Clinical Quality and Member Outcomes

Inovalon's Converged Quality Achieves 24th Consecutive NCQA HEDIS® Certification

Inovalon and MEDITECH Collaborate to Transform and Optimize Revenue Cycle

SaaS Healthcare Leader Joins MEDITECH Alliance to Optimize Patient Intake and Payment Processes SaaS Healthcare Leader Joins MEDITECH Alliance to Optimize Patient Intake and Payment Processes

Inovalon and MEDITECH Collaborate to Transform and Optimize Revenue Cycle

New Study From Inovalon and Genentech Finds Racial Disparities In Emergency Department Visits For Liver Cancer Care

Research Reveals How Social Drivers of Health Influence Higher Rates of Emergency Department Utilization for Black and Hispanic Hepatocellular Carcinoma Patients Research Reveals How Social Drivers of Health Influence Higher Rates of Emergency Department Utilization for Black and Hispanic Hepatocellular Carcinoma Patients

New Study From Inovalon and Genentech Finds Racial Disparities In Emergency Department Visits For Liver Cancer Care

AHF Files $50 Million Fraud Lawsuit Against Inovalon

WASHINGTON--(BUSINESS WIRE)--AHF Files $50 Million Fraud Lawsuit Against Inovalon.

AHF Files $50 Million Fraud Lawsuit Against Inovalon

Inovalon Acquires VigiLanz; a Leading Clinical Surveillance and Patient Safety SaaS and Data Company

BOWIE, Md.--(BUSINESS WIRE)--Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced the acquisition of VigiLanz, an industry leading, rapidly growing SaaS-based clinical surveillance and patient safety software and data company. Founded in 2001, VigiLanz is focused on advancing clinical surveillance, patient safety software, and related clinical data connectivity, helping hospitals, clinical facilities, clinicians, and life sciences com.

Inovalon Acquires VigiLanz; a Leading Clinical Surveillance and Patient Safety SaaS and Data Company

Michael Hasbany, Former Inovalon Executive, Joins Healthmine's Advisory Board

DALLAS--(BUSINESS WIRE)--Michael Hasbany, formerly of Inovalon, will provide analytical insights and strategic guidance to Healthmine's product strategy.

Michael Hasbany, Former Inovalon Executive, Joins Healthmine's Advisory Board

Innovator Lists December Power Buffer ETF

Innovator ETFs has listed the Innovator International Developed Power Buffer ETF – December (NYSE Arca: IDEC) as part of its lineup of Defined Outcome ETFs. IDEC seeks to track the return of the iShares MSCI EAFE ETF (EFA), up to a predetermined cap.

Innovator Lists December Power Buffer ETF

See News Rankings

Charts implemented using Lightweight Charts™